This statistic shows the leading companies in biotechnology and drugs in mainland China and Hong Kong according to Forbes in 2018, based on net income value. According to Forbes Asia's 200 Best Under a Billion 2019 list, the net income of Chinese company Pharmablock Sciences, engaged in the drug molecular block designing and process development business, amounted to approximately 20 million U.S. dollars in 2018.
Leading companies in biotechnology and drugs in mainland China and Hong Kong according to Forbes in 2018, based on net income value (in million U.S. dollars)*
*The data are based on Forbes Asia's 200 Best Under a Billion 2019 listing which includes only stock traded Asia-Pacific companies with annual revenue between five million and one billion U.S. dollars. From 24,000 candidates, roughly 1,400 passed Forbes' criteria for profitability, growth, and modest indebtedness. Forbes' selection of 200 finalists is un-ranked. The values represent the results of the most recent fiscal year.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Forbes. (July 10, 2019). Leading companies in biotechnology and drugs in mainland China and Hong Kong according to Forbes in 2018, based on net income value (in million U.S. dollars)* [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/944864/china-and-hong-kong-leading-biotechnology-companies-according-to-forbes-based-on-net-income/
Forbes. "Leading companies in biotechnology and drugs in mainland China and Hong Kong according to Forbes in 2018, based on net income value (in million U.S. dollars)*." Chart. July 10, 2019. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/944864/china-and-hong-kong-leading-biotechnology-companies-according-to-forbes-based-on-net-income/
Forbes. (2019). Leading companies in biotechnology and drugs in mainland China and Hong Kong according to Forbes in 2018, based on net income value (in million U.S. dollars)*. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/944864/china-and-hong-kong-leading-biotechnology-companies-according-to-forbes-based-on-net-income/
Forbes. "Leading Companies in Biotechnology and Drugs in Mainland China and Hong Kong According to Forbes in 2018, Based on Net Income Value (in Million U.S. Dollars)*." Statista, Statista Inc., 10 Jul 2019, https://www.statista.com/statistics/944864/china-and-hong-kong-leading-biotechnology-companies-according-to-forbes-based-on-net-income/
Forbes, Leading companies in biotechnology and drugs in mainland China and Hong Kong according to Forbes in 2018, based on net income value (in million U.S. dollars)* Statista, https://www.statista.com/statistics/944864/china-and-hong-kong-leading-biotechnology-companies-according-to-forbes-based-on-net-income/ (last visited November 21, 2024)
Leading companies in biotechnology and drugs in mainland China and Hong Kong according to Forbes in 2018, based on net income value (in million U.S. dollars)* [Graph], Forbes, July 10, 2019. [Online]. Available: https://www.statista.com/statistics/944864/china-and-hong-kong-leading-biotechnology-companies-according-to-forbes-based-on-net-income/
